CIRM Funded Clinical Trials

AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205

Disease Area:
B cell cancers
Investigator:
CIRM Grant:
CLIN2-14302 (Active)
Award Value:
$10,930,014.00
Trial Sponsor:
Angiocrine Bioscience, Inc.
Trial Stage:
Phase 3
Trial Status:
Closed
Targeted Enrollment:
130
ClinicalTrials.gov ID:

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov